Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities

被引:31
作者
Deuker, Marina [1 ,2 ]
Stolzenbach, Franziska [2 ,3 ]
Rosiello, Giuseppe [2 ,4 ,5 ]
Palumbo, Carlotta [2 ,6 ]
Martin, Thomas [2 ]
Tian, Zhe [2 ]
Chun, Felix K-H [1 ]
Saad, Fred [2 ]
Shariat, Shahrokh F. [7 ,8 ,9 ]
Kapoor, Anil [10 ]
Karakiewicz, Pierre, I [2 ]
机构
[1] Univ Hosp Frankfurt, Dept Urol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany
[2] Univ Montreal, Div Urol, Canc Prognost & Hlth Outcomes Unit, Hlth Ctr, Montreal, PQ, Canada
[3] Univ Hosp Hamburg Eppendorf, Martini Klin Prostate Canc Ctr, Hamburg, Germany
[4] IRCCS San Raffaele Sci Inst, Urol Res Inst, Dept Urol, Milan, Italy
[5] IRCCS San Raffaele Sci Inst, Urol Res Inst, Div Expt Oncol, Milan, Italy
[6] Univ Brescia, ASST Spedali Civili Brescia, Urol Unit, Dept Med & Surg Specialties,Radiol Sci & Publ Hlt, Brescia, Italy
[7] Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Vienna, Austria
[8] IM Sechenov First Moscow State Med Univ, Inst Urol & Reprod Hlth, Moscow, Russia
[9] Univ Jordan, Dept Urol, Amman, Jordan
[10] McMaster Univ, Juravinski Canc Ctr, Dept Surg, Div Urol, Hamilton, ON, Canada
关键词
carcinoma; renal cell; rhabdoid tumor; kidney neoplasms; histology; nephrectomy; RHABDOID FEATURES; KIDNEY; TUMORS; CLASSIFICATION;
D O I
10.1097/JU.0000000000001063
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We evaluated stage at presentation and cancer specific mortality according to variant histology relative to clear cell renal cell carcinoma. Materials and Methods: Within the Surveillance, Epidemiology, and End Results registry (2001-2016) we identified variant histology and clear cell renal cell carcinoma cases. Cumulative incidence plots, multivariate Cox regression models matched for stage, grade and other patient characteristics addressed cancer specific mortality. Subgroup analyses relied on inverse probability treatment weighting according to nephrectomy type. Results: Of all 69,785 patients with renal cell carcinoma 2,495 harbored variant histology (3.6%). Of patients with variant histology 70.1% (1,748) harbored sarcomatoid vs 11.2% (280) collecting duct vs 7.6% (190) mesenchymal vs 3.8% (94) neuroendocrine vs 2.9% (72) renal medullary vs 2.5% (62) mucinous tubular and spindle cell, and 2.0% (49) rhabdoid tumors. All patients with variant histology exhibited more advanced TNM stage at diagnosis than clear cell renal cell carcinoma, except for mucinous tubular and spindle cell. After matching with G4 clear cell renal cell carcinoma, collecting duct (multivariate HR 1.6, p <0.01), sarcomatoid (HR 1.8, p <0.01), renal medullary (HR 1.7, p=0.1) and rhabdoid variant histology (HR 1.5, p=0.1) showed higher cancer specific mortality than clear cell renal cell carcinoma. No cancer specific mortality differences were recorded for mesenchymal, neuroendocrine and mucinous tubular and spindle cell variant histology. In nephrectomy subgroup higher cancer specific mortality was recorded after partial nephrectomy than radical nephrectomy in sarcomatoid variant histology after inverse probability treatment weighting and multivariate adjustment (HR 1.2, p=0.02). Conclusions: TNM stage at diagnosis is universally more advanced in patients with variant histology, except for mucinous tubular and spindle cell. Cancer specific mortality is higher in collecting duct, sarcomatoid, rhabdoid and renal medullary variant histology, but not in other variant histology. Partial nephrectomy is associated with worse survival in sarcomatoid variant histology but could not be assessed in other variant histology due to small sample size.
引用
收藏
页码:671 / 675
页数:5
相关论文
共 30 条
[1]   Survival outcomes in sarcomatoid renal cell carcinoma [J].
Al-Juhaishi, Taha ;
Alder, Laura ;
Paul, Asit K. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[2]   Sarcomatoid Renal Cell Carcinoma: Population-Based Study of 879 Patients [J].
Alevizakos, Michail ;
Gaitanidis, Apostolos ;
Nasioudis, Dimitrios ;
Msaouel, Pavlos ;
Appleman, Leonard J. .
CLINICAL GENITOURINARY CANCER, 2019, 17 (03) :E447-E453
[3]  
[Anonymous], N.H. Rev. Stat. Ann.
[4]   Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies [J].
Austin, Peter C. ;
Stuart, Elizabeth A. .
STATISTICS IN MEDICINE, 2015, 34 (28) :3661-3679
[5]   Renal Medullary Carcinoma: a Report of the Current Literature [J].
Blas, Leandro ;
Roberti, Javier ;
Petroni, Jorgelina ;
Reniero, Liliana ;
Cicora, Federico .
CURRENT UROLOGY REPORTS, 2019, 20 (01)
[6]   Sarcomatoid renal cell carcinoma - An examination of underlying histologic subtype and an analysis of associations with patient outcome [J].
Cheville, JC ;
Lohse, CM ;
Zincke, H ;
Weaver, AL ;
Leibovich, BC ;
Frank, I ;
Blute, ML .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (04) :435-441
[7]   Outcomes of patients with sarcomatoid renal cell carcinoma: The Mayo Clinic experience [J].
Costello, Brian Addis ;
Zhang, Ben ;
Lohse, Christine M. ;
Boorjian, Stephen A. ;
Cheville, John ;
Leibovich, Bradley C. ;
Thompson, Robert Houston .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
[8]   Malignant solitary fibrous tumour of the kidney with an extensive thrombus: A case report and review of the literature [J].
Couture, Felix ;
Legault, Benjamin ;
Ekindi, Nadia ;
Noel-Lamy, Maxime ;
Pavic, Michel ;
Richard, Patrick O. .
UROLOGY CASE REPORTS, 2019, 26
[9]   Grading of renal cell carcinoma [J].
Delahunt, Brett ;
Eble, John N. ;
Egevad, Lars ;
Samaratunga, Hemamali .
HISTOPATHOLOGY, 2019, 74 (01) :4-17
[10]  
Gökden N, 2000, AM J SURG PATHOL, V24, P1329